Do you want to read an article? Please log in or register.
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial
Lung Cancer
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)